...Pharmaceutical Supply Chain Abstract • The global pharmaceutical supply chain is very complex and critical to a $650 billion dollar value industry which ensures the world population has necessary medicines. • Manufacturers have the responsibility to produce sufficient quantities of drugs to meet a growing global demand while maintaining quality to ensure safety. • Global and local regulatory agencies around the world have a daunting task to monitor manufacturers, raw material suppliers, and stem counterfeit pharmaceutical production. • Wholesale distributors, importers, and retail pharmacies have a large amount of power in the supply chain as they pull the demand from the manufacturers and provide the medicines to end-consumers. • In a changing industry where there are fewer blockbuster drugs and increasing use of generic offerings, manufacturers as well as participants at all levels of the supply chain must look for areas to improve efficiencies to be profitable in the long-run. Pharmaceutical Supply Chain Analysis 2 Introduction A transparent and efficient pharmaceutical supply chain contributes significantly towards improving the availability of essential medications. The reality across the world is that pharmaceutical supply and distribution consists of different stakeholders from both the public and private sectors to create complex systems. In a heavily regulated field, globalization has placed increasing demands on regulatory agencies to ensure the safety and...
Words: 6177 - Pages: 25
...The determinants and Challenges in Supply Chain of Pharmaceuticals in South West Region Contents The determinants and Challenges in Supply Chain of Pharmaceuticals Fund and Supply Agency (PFSA) 1 Jimma Hub to Supply Quality Assured Essential pharmaceuticals to Health Facilities in South West Region 1 !Unexpected End of Formula 1. Introduction 2 1.1. Statement of the Problem 3 1.2. Study goal, objectives and indicators 3 1.2.1. Goal 3 1.2.2. Objective & Indicators 3 1.3. Hypothesis 4 1.4. Significance of the Study 4 1.5. Scope of the Study 5 2. Literature Review 5 2.1. TODAY'S CHALLENGES 6 2.2. Supply Chain Pain Points 6 2.2.1. Lack of Visibility, Particularly Upstream 6 2.2.2. Alignment with Third-Party Service Providers 7 2.2.3. Supply Chain Traceability 7 3. Methodology 8 3.1. Sources of Data 8 3.2. Method of Sampling Technique 8 3.3. Method of Data Collection 8 3.4. Study Population 8 3.5. Plan of Action 9 3.6. Management Plan 9 4. Conclusion 10 5. References 11 Abstract The Pharmaceuticals Fund and Supply Agency is focusing on supplying 100% Essential Medicines to public health facilities. The focus stems from the increasing health problem of the public that the health facilities should address accordingly. The objective of this study is, therefore, to identify challenges in supply chain of pharmaceuticals and determining factors that contribute to these challenges at PFSA Jimma hub. The study will use both an observational...
Words: 2866 - Pages: 12
...OR ACHIEVEMENTS EXPRESSED OR IMPLIED BY SUCH FORWARDLOOKING STATEMENTS. IMPORTANT FACTORS THAT COULD CAUSE OR CONTRIBUTE TO SUCH DIFFERENCES INCLUDE RISKS RELATING TO: TEVA'S ABILITY TO ACCURATELY PREDICT FUTURE MARKET CONDITIONS, TEVA'S ABILITY TO SUCCESSFULLY DEVELOP AND COMMERCIALIZE ADDITIONAL PHARMACEUTICAL PRODUCTS, THE INTRODUCTION OF COMPETING GENERIC EQUIVALENTS, THE EXTENT TO WHICH TEVA MAY OBTAIN U.S. MARKET EXCLUSIVITY FOR CERTAIN OF ITS NEW GENERIC PRODUCTS AND REGULATORY CHANGES THAT MAY PREVENT TEVA FROM UTILIZING EXCLUSIVITY PERIODS, COMPETITION FROM BRAND-NAME COMPANIES THAT ARE UNDER INCREASED PRESSURE TO COUNTER GENERIC PRODUCTS, OR COMPETITORS THAT SEEK TO DELAY THE INTRODUCTION OF GENERIC PRODUCTS, POTENTIAL LIABILITY FOR SALES OF GENERIC PRODUCTS PRIOR TO A FINAL RESOLUTION OF OUTSTANDING PATENT LITIGATION, INCLUDING THAT RELATING TO THE GENERIC VERSIONS OF ALLEGRA , NEURONTIN , LOTREL , FAMVIR , AND PROTONIX , THE IMPACT OF CONSOLIDATION OF OUR DISTRIBUTORS AND CUSTOMERS, THE EFFECTS OF COMPETITION ON OUR INNOVATIVE PRODUCTS, ESPECIALLY COPAXONE SALES, THE IMPACT OF PHARMACEUTICAL INDUSTRY REGULATION AND PENDING LEGISLATION THAT COULD AFFECT THE PHARMACEUTICAL INDUSTRY, THE DIFFICULTY OF PREDICTING U.S. FOOD AND DRUG ADMINISTRATION, EUROPEAN MEDICINES AGENCY AND OTHER REGULATORY AUTHORITY APPROVALS, THE REGULATORY ENVIRONMENT AND CHANGES IN THE HEALTH POLICIES AND STRUCTURES OF VARIOUS COUNTRIES, OUR ABILITY TO ACHIEVE EXPECTED RESULTS THOUGH OUR...
Words: 7679 - Pages: 31
...Filling baby bottles and soothing aching joints are a habit for Abbott. Abbott Laboratories is a top health care products manufacturer. Its pharmaceuticals include HIV treatments Norvir and Kaletra, rheumatoid arthritis therapy Humira, and Lupron to treat endometriosis and prostate cancer. Its nutritional products division makes such well-known brands as Similac infant formula and the Ensure line of nutrition supplements. But at the same time, its competitors are having different strengths and weaknesses to make them surviving in milk powder industry and to compete with Abbott. The two main competitors of Abbott in Hong Kong that we are focusing on is Mead Johnson and Wyeth, the comparison of strengths and weaknesses will be discussed below. For Mead Johnson, it is a global nutritional company. Mead Johnson has aggressive marketing initiatives, especially driven by Direct-to-Consumer campaigns. Its adult formulas are not perceived as a premium product. The similarities of the strengths for Mead Johnson and Abbott are that, both of the companies, Mead Johnson and Abbott, are very well known for its wide range of infant milk production. Both of them are recognized as nutritional expertise locally, nationally and internationally as their products are distributed in more than 100 countries. Second, both of them are famous in US market. Abbott had 20% in 2009 while Mead Johnson had 32%. Third, they both emphasize their own innovative research and development technology. For Abbott...
Words: 996 - Pages: 4
...extended to the world’s largest private communication system in the United States (Wail gum, T., 2007). This communication linked all the Wal-Mart stores back to the central headquarters in Bentonville Arkansas to store all of the company information. Having this communication link in place it would ensure a better track of inventory and profits of all locations of Wal-Mart. Walton wanted to ensure that everyone received products from Wal-Mart all over the world by mail, telephone and the internet. Wal-Mart.com came about soon after this alone with the New York stock. Wal-Mart then became more international with this leading source of technology. Too many Wal-Marts are the world’s top retailer that uses technology to reinvent global supply chains. However, other companies from the around the world has...
Words: 600 - Pages: 3
...agribusiness solutions for the farmers as well as customers by having fertilizer division. The analysis demonstrates the importance of trade-offs, innovation, product development, line of fit and Information Technology systems in the operations strategy, while showing decentralization structure and effect of it on global companies. Introduction Bunge limited is a successful example for transformation of companies to globalization as Bunge CEO Weisser goal to become the best company in the world in agribusiness and food. Performance objectives indicating market requirements from quality, speed, dependability, flexibility and cost for companies to position themselves in the market while decisions areas for operations strategy as capacity, supply network, process technology, and development and organization for companies to set their operation resources capabilities achieving the performance required in the market to reach and maintain the intended market position as a vital part of...
Words: 1973 - Pages: 8
...11.1 Logistics In both vertical and horizontal marketing systems, systematised information contributes to the efficient flow of goods and services from the point-of-origin to the point-of-consumption. This process of regulation begins with customer service and extends to the procurement, handling, and processing of resources aimed at delivering customer satisfaction. All ways in which resources are procured, handled, and processed fall within a set of activities known as logistics. Logistics is a process of systematising information to facilitate the efficient and cost-effective flows of goods and services to produce customer satisfaction. Each member in the supply chain must be involved in logistics activities. Logistics flows may begin with the supplier/manufacturer relationship, but efficient logistics activities are needed throughout the marketing channel. Relationship marketing epitomises the interac-tive process necessary to achieve customer satisfaction by maintaining a participative exchange of information with all of a firm’s channel partners. In addition, develop-ments in electronic retailing are now aimed at making this whole process more effective and efficient. The Council of Logistics Management defines logistics management as: ‘The process of planning, implementing and controlling the efficient, cost-effective flow and storage of raw materials, in-process inventory, finished goods, and related information from point-of-origin to point-of-consumption for...
Words: 3844 - Pages: 16
...l287/inte.l050.0187 ISSN 0092-21021 EissN 1526-551X1061360310194 @ 2006 INFORMS 3, May-June Strategic Planning Production Bernhard and Logistics, Germany, of BMW's Network Fleischmann University of Augsburg, Global of Production Department D-86135 Augsburg, Universit?tsstra?e 16, bernhard.fleischmann@wiwi.uni-augsburg.de BMW AG, D-80788 Sonja Ferber, Peter Henrich M?nchen, Germany (sonja.ferber@bmw.de, peter.henrich@bmw.de) We sites cars developed over a to the a strategic-planning planning markets. model horizon. It determines 12-year assembly, improved Key words: global and paint shop, the transparency to BMW's allocation of various optimize as well It includes the supply of materials the investments in...
Words: 6024 - Pages: 25
...Masters of rural markets: Accenture Research Report The Hallmarks of High Performance Contents Foreword: Unleashing India’s rural multiplier effect Growing business confidence in rural opportunities The attractions and distractions of rural markets 03 05 09 Distinctive capabilities that enable 15 companies to succeed in India’s hinterland Framework factors critical to nurturing distinctive capabilities Developing the right capabilities—and acting on them Last word 28 29 31 2 Foreword Unleashing India’s rural multiplier effect But rural India’s contributions to the nation’s economic success—and the obvious potential for profitable growth—is just a part of the promise of wholehearted commitment to doing business beyond the city centers and suburbs. India’s rural markets offer unprecedented opportunities for global and local companies to experiment with approaches and business models, which if successful, may be replicated in rural markets of other emerging economies. India is on the march. Its momentum is not only evident in metros— it is apparent in small towns and villages as well. Collectively, all over India’s rural heartland and in its teeming cities, India is readying for an even more impressive era of economic growth. There is no question that India’s rural markets are becoming a powerful economic engine. One telltale sign: rural accounts now comprise over 50 percent of new subscribers for some of the leading telecom providers.1 The rural multiplier...
Words: 10004 - Pages: 41
...Li & Fung Limited Press Conference August 12, 2010 Interim Results 2010 Interim Results Highlights • Record high growth of core operating profit over a half-year period • Record high margins due to strong onshore businesses and increasing involvement in value-added services • Delivered strong operating leverage with continued cost savings • Turnover modestly improved, reflecting the effects of early stage of the economic recovery together with contributions from previous acquisitions and outsourcing deals announced acquisition of 7 companies, and signed 4 licensing deals so far this year • Entered into a landmark sourcing deal with Wal-Mart Stores, Inc., 2010 Interim Results Highlights (HK$m) Turnover (US$m*) Total Margin % of sales Core Operating Profit % of sales Profit Attributable to Shareholders % of sales 1H 2009 46,292 5,935 5,395 11.7% 1,697 3.7% 1,397 3.0% 1H 2010 51,792 6,640 6,998 13.5% 2,635 5.1% 2,171 4.2% *USD1 = HKD7.8 Change 12% 30% 55% 55% 2010 Interim Results Per Share Data (HK Cents) 1H 2009 1H 2010 Change EPS 38.3¢ 57.5¢ 50% Interim Dividend 26.0¢ 38.0¢ 46% 2010 Interim Results Analysis--Net Profit (HK$m) In HK$m Core Operating Profit % of sales Amortization of intangible assets from acquisitions Notional Interest Net Interest (excluding notional interest) Associates Tax Minority Interest Profit attributable to shareholders % of sales Actuals 1H 2009 1H 2010 1,697 2,635 3.7% 5.1% (48) (49) (127)...
Words: 1298 - Pages: 6
...IT TAKES A LEADER TO TAKE YOU PLACES. A n n u A l r e p o r t 2 0 1 2 2 0 1 3 Growth is… movinG from strenGth to strenGth Flamingos, known for their undeniable beauty, are also recognised as a species that stays strong by sticking together, no matter how trying the circumstances are. But for a flock to be strong, it needs an equally resilient leader to take them in the right direction. Just like Gati, the leader of the logistics industry in India. Gati Limited is India’s leader in providing Express Distribution services, Supply Chain Solutions, Cold Chain Transportation Solutions, Warehousing, International Freight Forwarding, Custom Clearance and e-Commerce Solutions. Founded in 1989 as a cargo management company, Gati pioneered Express Distribution Services in India. With a track record of 24 years, Gati is one of India’s most coveted companies, employing 3500 people, and serving over 5000 customers – including the top 10 brands in the Automotive, Healthcare, Engineering and Consumer Durables industry. Gati has a strong market presence in the Asia Pacific region and SAARC countries, with offices in China, Singapore, Hong Kong, Thailand and Nepal, and has plans to foray into other markets. In a Company where every employee demonstrates dedication and commitment to succeed, its little wonder that Gati is the leader, taking the industry places. values are… a force to be reckoned with Flamingos, as is ingrained in their DNAs for centuries, instinctively have values that...
Words: 43055 - Pages: 173
...SUPPLY CHAIN AT PFIZER Global pharmaceutical companies are modelled with a supply chain, which ensures that the right drug reaches the right people at the right time and in the right condition. The pharmaceutical firms also ensure 100% product availability at optimum cost by carrying huge inventory, which maintains 100% fill rate. Manufacturers are also trying to cut down development time to save costs. So, pharmaceutical companies today are designing the supply chain to be as responsive as possible to reduce entry time to the market thereby increasing profit margins. PFIZER’S GLOBAL SUPPLY CHAIN Complexity of Pfizer Supply chain can be judged from the following numbers: 3000+ Formulations 89 Manufacturing Sites 200 Transportation Centres 500+ Suppliers 54 Internal Logistics Centres 175 sites for distribution networks A unique feature of the Pfizer’s supply chain is that it operates two very different types of supply chains at all times. One supply chain supports the drug development phase and the other one to sell a successful drug in the market. While one supply chain is focused on facilitating a quick completion of the clinical trials to obtain a quick approval, the aim of the other supply chain is to meet sales targets. As a result the drivers motivating the supply chain design are speed and high availability respectively. After a drug is launched, a completely different set of objectives, drivers, and constraints become dominant. Now, the focus shifts from...
Words: 401 - Pages: 2
...Building Supply Chain Capabilities in the Pharmaceutical Industry Part 2: Winning supply chain capabilities UPS Supply Chain SolutionsSM Copyright © 2005 United Parcel Service of America, Inc. All Rights Reserved. No part of this publication may be reproduced without the prior written permission of UPS Supply Chain Solutions. Our Insight. A UPS Supply Chain Solutions White Paper In “Building Supply Chain Management Capabilities in the Pharmaceutical Industry Part 1: Trends Impacting the Supply Chain,” we explored the business implications of major trends impacting pharmaceutical supply chains. Unless pharmaceutical companies begin taking action now to create more business-effective cost and process structures, survival will be at stake. These trends are having the greatest impact on sales and marketing, channel management, and new product development and rollout. Ultimately, we believe these trends and implications are converging to create an environment in which price pressures are becoming so intense that a growing number of pharmaceutical companies will struggle to meet shareholder expectations. Unless pharmaceutical companies begin taking action now to create more businesseffective cost and process structures, survival will be at stake. We propose that the winning pharmaceutical companies will build differentiating capability in five supply chain areas: • • • • • Production Fulfillment Customer Management Forecasting & Planning Procurement AS THE MEGA MERGER...
Words: 4244 - Pages: 17
...aberidoost et al. DARU Journal of Pharmaceutical Sciences 2013, 21:69 http://www.darujps.com/content/21/1/69 REVIEW ARTICLE Open Access Pharmaceutical supply chain risks: a systematic review Mona Jaberidoost1, Shekoufeh Nikfar1, Akbar Abdollahiasl1,2 and Rassoul Dinarvand1,3* Abstract Introduction: Supply of medicine as a strategic product in any health system is a top priority. Pharmaceutical companies, a major player of the drug supply chain, are subject to many risks. These risks disrupt the supply of medicine in many ways such as their quantity and quality and their delivery to the right place and customers and at the right time. Therefore risk identification in the supply process of pharmaceutical companies and mitigate them is highly recommended. Objective: In this study it is attempted to investigate pharmaceutical supply chain risks with perspective of manufacturing companies. Methods: Scopus, PubMed, Web of Science bibliographic databases and Google scholar scientific search engines were searched for pharmaceutical supply chain risk management studies with 6 different groups of keywords. All results found by keywords were reviewed and none-relevant articles were excluded by outcome of interests and researcher boundaries of study within 4 steps and through a systematic method. Results: Nine articles were included in the systematic review and totally 50 main risks based on study outcome of interest extracted which classified in 7 categories. Most of reported...
Words: 4846 - Pages: 20
...ANALYSIS OF SUPPLY CHAIN RISK MANAGEMENT IN THE GHANAIAN MANUFACTURING INDUSTRY: A CASE STUDY OF KAMA PHARMACEUTICAL MANUFACTURING COMPANY INTRODUCTION 1.0 Background of the Study According to Hendricks and Singhal (2005), there is increased awareness and recognition among managers, consultants and academicians that supply chain performance is increasingly important to business success. In other words, supply chain plays an important strategic role in the world economy and that firms are more dependent upon their supply chains networks in order to deliver value. Regrettably, there is also a point of vulnerability in the world economy which are subject to disruptions with significant consequences especially when the disruption comes suddenly, without warning, and with devastation. Handfield (2007) posit that the total set of risks to an organization is much broader. It includes hazard risk and operational risk. Hazard risks refer to weather disasters, equipment shutdown, or product liability, while operational risks include major disruptions such as theft, late supplier deliveries, and IT systems shutdowns and so on. For the purpose of this study, focus shall be placed on operational risk with specific focus on supply chain risk. Generally, supply chain operation is fundamental to the success of any organization. It is critical to a company’s ability to manage global operations, supply and demand volatility, the accelerated pace of new product and services introductions...
Words: 8147 - Pages: 33
